50 related articles for article (PubMed ID: 29309772)
1. Somatic mutations precede acute myeloid leukemia years before diagnosis.
Desai P; Mencia-Trinchant N; Savenkov O; Simon MS; Cheang G; Lee S; Samuel M; Ritchie EK; Guzman ML; Ballman KV; Roboz GJ; Hassane DC
Nat Med; 2018 Jul; 24(7):1015-1023. PubMed ID: 29988143
[TBL] [Abstract][Full Text] [Related]
2. [Expectations and challenges for clinical application of cancer genome panels in acute myeloid leukemia].
Chi S
Rinsho Ketsueki; 2024; 65(5):343-352. PubMed ID: 38825513
[TBL] [Abstract][Full Text] [Related]
3. Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia.
Qin G; Dai J; Chien S; Martins TJ; Loera B; Nguyen QH; Oakes ML; Tercan B; Aguilar B; Hagen L; McCune J; Gelinas R; Monnat RJ; Shmulevich I; Becker PS
Clin Cancer Res; 2024 Apr; ():OF1-OF13. PubMed ID: 38619278
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of cancer genomes: back to the future.
Walter MJ; Graubert TA; Dipersio JF; Mardis ER; Wilson RK; Ley TJ
Per Med; 2009 Nov; 6(6):653. PubMed ID: 20161678
[TBL] [Abstract][Full Text] [Related]
5. The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia.
Zhao H; Zhu H; Huang J; Zhu Y; Hong M; Zhu H; Zhang J; Li S; Yang L; Lian Y; Wang S; Mao J; Chen Y; Li J; Qian S
Leuk Res; 2018 Mar; 66():1-7. PubMed ID: 29331774
[TBL] [Abstract][Full Text] [Related]
6. Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
Strickland SA; Shaver AC; Byrne M; Daber RD; Ferrell PB; Head DR; Mohan SR; Mosse CA; Moyo TK; Stricker TP; Vnencak-Jones C; Savona MR; Seegmiller AC
Leuk Res; 2018 Feb; 65():67-73. PubMed ID: 29310020
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.
Blair AB; Groot VP; Gemenetzis G; Wei J; Cameron JL; Weiss MJ; Goggins M; Wolfgang CL; Yu J; He J
J Am Coll Surg; 2018 Apr; 226(4):630-637.e1. PubMed ID: 29309945
[TBL] [Abstract][Full Text] [Related]
8. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
9. Mutation profile and associated clinical features in Chinese patients with cytogenetically normal acute myeloid leukemia.
Wang S; Zhang YX; Huang T; Sui JN; Lu J; Chen XJ; Wang KK; Xi XD; Li JM; Huang JY; Chen B
Int J Lab Hematol; 2018 Aug; 40(4):408-418. PubMed ID: 29573577
[TBL] [Abstract][Full Text] [Related]
10. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
[No Abstract] [Full Text] [Related]
11. Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia.
Yu J; Li Y; Li T; Li Y; Xing H; Sun H; Sun L; Wan D; Liu Y; Xie X; Jiang Z
Exp Hematol Oncol; 2020; 9():2. PubMed ID: 31921515
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the clinical characteristics and prognosis of adult
Sheng L; Liu Y; Zhu Y; Zhou J; Hua H
Open Med (Wars); 2023; 18(1):20230830. PubMed ID: 38025540
[TBL] [Abstract][Full Text] [Related]
13. An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment.
Sandoval C; Calle Y; Godoy K; Farías J
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047003
[TBL] [Abstract][Full Text] [Related]
14. Mutation profile of acute myeloid leukaemia in a Chinese cohort by targeted next-generation sequencing.
Lit BMW; Guo BB; Malherbe JAJ; Kwong YL; Erber WN
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1573. PubMed ID: 34617422
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of recurrent gene mutations in acute myeloid leukemia.
Yu J; Li Y; Zhang D; Wan D; Jiang Z
Exp Hematol Oncol; 2020; 9():4. PubMed ID: 32231866
[TBL] [Abstract][Full Text] [Related]
16. Targeted Next Generation Sequencing to study insert stability in genetically modified plants.
Boutigny AL; Barranger A; De Boisséson C; Blanchard Y; Rolland M
Sci Rep; 2019 Feb; 9(1):2308. PubMed ID: 30783176
[TBL] [Abstract][Full Text] [Related]
17. Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis.
Han X; Li W; He N; Feng P; Pang Y; Ji C; Ma D
Clin Chim Acta; 2018 Apr; 479():25-37. PubMed ID: 29309772
[TBL] [Abstract][Full Text] [Related]
18. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
